当前位置:首页 - 行情中心 - 申联生物(688098) - 财务分析 - 现金流量表

申联生物

(688098)

  

流通市值:34.29亿  总市值:34.29亿
流通股本:4.11亿   总股本:4.11亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金75,824,873.4441,392,811.53264,488,020.21146,597,121.05
  收到其他与经营活动有关的现金7,024,883.33,720,845.5614,454,629.5813,216,306.43
  经营活动现金流入小计82,849,756.7445,113,657.09278,942,649.79159,813,427.48
  购买商品、接受劳务支付的现金45,760,089.1420,145,578.2263,631,869.6839,621,687.24
  支付给职工以及为职工支付的现金40,881,622.2624,021,273.9775,551,783.2859,830,942.11
  支付的各项税费13,193,778.333,435,951.7312,230,589.959,544,113.96
  支付其他与经营活动有关的现金47,678,376.8937,585,659.7294,451,565.3468,922,778.29
  经营活动现金流出小计147,513,866.6285,188,463.64245,865,808.25177,919,521.6
  经营活动产生的现金流量净额-64,664,109.88-40,074,806.5533,076,841.54-18,106,094.12
二、投资活动产生的现金流量:
  收回投资收到的现金189,538,951.36177,538,951.36590,000,000476,000,000
  取得投资收益收到的现金111,177.31293,986.13,552,514.73914,545.51
  处置固定资产、无形资产和其他长期资产收回的现金净额30,000-517,000517,000
  投资活动现金流入小计189,680,128.67177,832,937.46594,069,514.73477,431,545.51
  购建固定资产、无形资产和其他长期资产支付的现金13,701,992.566,516,789.5445,233,904.9734,279,805.21
  投资支付的现金194,441,789171,000,000598,000,000459,500,000
  投资活动现金流出小计208,143,781.56177,516,789.54643,233,904.97493,779,805.21
  投资活动产生的现金流量净额-18,463,652.89316,147.92-49,164,390.24-16,348,259.7
三、筹资活动产生的现金流量:
  取得借款收到的现金40,000,000---
  收到其他与筹资活动有关的现金16,198,348.02-16,317.3816,317.38
  筹资活动现金流入平衡项目0-00
  筹资活动现金流入小计56,198,348.02-16,317.3816,317.38
  偿还债务支付的现金560,000-1,120,000560,000
  分配股利、利润或偿付利息支付的现金210,204.5462,790265,689.67202,202
  支付其他与筹资活动有关的现金218,34798,4132,136,887.392,008,660.95
  筹资活动现金流出小计988,551.54161,2033,522,577.062,770,862.95
  筹资活动产生的现金流量净额55,209,796.48-161,203-3,506,259.68-2,754,545.57
四、汇率变动对现金及现金等价物的影响-46-23.13-33.72-17.51
五、现金及现金等价物净增加额-27,918,012.29-39,919,884.76-19,593,842.1-37,208,916.9
  加:期初现金及现金等价物余额91,575,251.791,575,251.7111,169,093.8111,169,093.8
  期末现金及现金等价物余额63,657,239.4151,655,366.9491,575,251.773,960,176.9
补充资料:
  净利润-20,357,785.58--24,971,591.4-
  资产减值准备11,582.17--6,259.52-
  固定资产和投资性房地产折旧33,512,023.03-64,028,971.82-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧33,512,023.03-64,028,971.82-
  无形资产摊销6,001,081.36-10,999,425.83-
  处置固定资产、无形资产和其他长期资产的损失197,942.15--260,766.69-
  固定资产报废损失--43,224.45-
  公允价值变动损失351,384.03--2,402,823.06-
  财务费用270,326.25-580,993.74-
  投资损失1,052,162.51-3,004,545.84-
  递延所得税-3,556,610--1,363,130.4-
  其中:递延所得税资产减少-3,532,100.3--1,213,951.03-
    递延所得税负债增加-24,509.7--149,179.37-
  存货的减少-23,363,312.05-635,434.24-
  经营性应收项目的减少-42,521,180.72--34,224,762.95-
  经营性应付项目的增加-25,209,538.71-3,291,653.75-
  现金的期末余额63,657,239.41-91,575,251.7-
  减:现金的期初余额91,575,251.7-111,169,093.8-
  现金及现金等价物的净增加额-27,918,012.29--19,593,842.1-
公告日期2026-08-312026-04-292026-04-292025-10-27
审计意见(境内)标准无保留意见
TOP↑